INSIGHTS ON DRUG DEVELOPMENT
-
Recapitulating Inflammation: How To Use the Colon Intestine-Chip To Study Complex Mechanisms Of IBD
To address the challenges associated with conventional drug development models, a Colon Intestine-Chip has been developed to recapitulate the biology that drives inflammatory bowel disease.
-
Ex Vivo Systems: Translating Mechanisms To Human Oncology
Watch to learn how Champions Oncology is advancing the development of oncology drugs through the creation of complex in vitro models using patient-derived TumorGrafts.
-
Spray Dried Dispersions In Controlled Release Formulations
Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.
-
Right From The Start: Smarter Developability For Stronger Formulations
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
-
Are You Keeping Pace With Oligo Synthesis Optimization?11/18/2025
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
Innovating The mAb Characterization Process11/14/2024
Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.
-
The Next Generation Of Thermal Stability Testing For Biologic Drugs10/3/2024
Achieving precise measurements in a high-throughput setting can be challenging without disrupting workflows or deadlines. Learn about a new tool for rapid biotherapeutic thermal stability characterization.
-
Using AI-Analysis And High-Content Screening To Improve Data Capturing4/4/2025
Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.
-
Using SEC For Reliable Biotherapeutic Peptide Analysis7/31/2025
Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.
DRUG DEVELOPMENT SOLUTIONS
-
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.
-
Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.